Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wyatt, Paulishak"'
Autor:
Mariam Oladejo, Hong-My Nguyen, Ashok Silwal, Britney Reese, Wyatt Paulishak, Maciej M. Markiewski, Laurence M. Wood
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Targeting tumor-associated angiogenesis is currently at the forefront of renal cell carcinoma (RCC) therapy, with sunitinib and bevacizumab leading to increased survival in patients with metastatic RCC (mRCC). However, resistance often occurs shortly
Externí odkaz:
https://doaj.org/article/8d8d0892bcd349818ff349fad6d22f6e
Publikováno v:
Breast Cancer. 30:167-186
Heterogeneity of the tumor microenvironment (TME) and the lack of a definite targetable receptor in triple-negative breast cancer (TNBC) has carved a niche for this cancer as a particularly therapeutically challenging form of breast cancer. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f6924a48a66494a6277802076a89963
https://doi.org/10.1007/s12282-022-01415-4
https://doi.org/10.1007/s12282-022-01415-4
Publikováno v:
Cancer immunology, immunotherapy : CII.
Renal cell carcinoma (RCC) is the deadliest form of urological cancer and is projected to be the fourth most common neoplasm in the USA in males by 2040. In addition to the current poor prognosis with 5-year survival rates hardly reaching 15%, the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8246fc79220a348fd40e32ca56347769
https://pubmed.ncbi.nlm.nih.gov/36562824
https://pubmed.ncbi.nlm.nih.gov/36562824
Publikováno v:
Seminars in cancer biology. 88
Cancer vaccines and immune checkpoint inhibitors (ICIs) function at different stages of the cancer immune cycle due to their distinct mechanisms of action. Therapeutic cancer vaccines enhance the activation and infiltration of cytotoxic immune cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eccf14460caffe100e19897d7c872cb1
https://pubmed.ncbi.nlm.nih.gov/36526110
https://pubmed.ncbi.nlm.nih.gov/36526110
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1237
Volume 15
Issue 4
Pages: 1237
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in both men and women in the United States. While immune checkpoint inhibitor (ICI) therapy is demonstrating remarkable clinical responses, the resistance and immune-related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f22746a76b4d7c0aee7c2cfaab06905e
https://doi.org/10.3390/cancers15041237
https://doi.org/10.3390/cancers15041237